These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1195 related articles for article (PubMed ID: 9253308)

  • 1. Physiological changes in dehydroepiandrosterone are not reflected by serum levels of active androgens and estrogens but of their metabolites: intracrinology.
    Labrie F; Bélanger A; Cusan L; Candas B
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2403-9. PubMed ID: 9253308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Marked decline in serum concentrations of adrenal C19 sex steroid precursors and conjugated androgen metabolites during aging.
    Labrie F; Bélanger A; Cusan L; Gomez JL; Candas B
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2396-402. PubMed ID: 9253307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravaginal prasterone (DHEA) provides local action without clinically significant changes in serum concentrations of estrogens or androgens.
    Labrie F; Martel C; Bérubé R; Côté I; Labrie C; Cusan L; Gomez JL
    J Steroid Biochem Mol Biol; 2013 Nov; 138():359-67. PubMed ID: 23954500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum steroid concentrations remain within normal postmenopausal values in women receiving daily 6.5mg intravaginal prasterone for 12 weeks.
    Martel C; Labrie F; Archer DF; Ke Y; Gonthier R; Simard JN; Lavoie L; Vaillancourt M; Montesino M; Balser J; Moyneur É;
    J Steroid Biochem Mol Biol; 2016 May; 159():142-53. PubMed ID: 26972555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in serum DHEA and eleven of its metabolites during 12-month percutaneous administration of DHEA.
    Labrie F; Cusan L; Gomez JL; Martel C; Bérubé R; Bélanger P; Chaussade V; Deloche C; Leclaire J
    J Steroid Biochem Mol Biol; 2008 May; 110(1-2):1-9. PubMed ID: 18359622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum levels of sex steroids and metabolites following 12 weeks of intravaginal 0.50% DHEA administration.
    Ke Y; Labrie F; Gonthier R; Simard JN; Bergeron D; Martel C; Vaillancourt M; Montesino M; Lavoie L; Archer DF; Balser J; Moyneur E;
    J Steroid Biochem Mol Biol; 2015 Nov; 154():186-96. PubMed ID: 26291918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioavailability and metabolism of oral and percutaneous dehydroepiandrosterone in postmenopausal women.
    Labrie F; Bélanger A; Labrie C; Candas B; Cusan L; Gomez JL
    J Steroid Biochem Mol Biol; 2007 Oct; 107(1-2):57-69. PubMed ID: 17627814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioavailability and pharmacokinetics of dehydroepiandrosterone in the cynomolgus monkey.
    Leblanc M; Labrie C; Bélanger A; Candas B; Labrie F
    J Clin Endocrinol Metab; 2003 Sep; 88(9):4293-302. PubMed ID: 12970301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in serum concentrations of conjugated and unconjugated steroids in 40- to 80-year-old men.
    Bélanger A; Candas B; Dupont A; Cusan L; Diamond P; Gomez JL; Labrie F
    J Clin Endocrinol Metab; 1994 Oct; 79(4):1086-90. PubMed ID: 7962278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ovarian and adrenal contributions to peripheral steroid levels in postmenopausal women.
    Maroulis GB; Abraham GE
    Obstet Gynecol; 1976 Aug; 48(2):150-4. PubMed ID: 133306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral dehydroepiandrosterone for adrenal androgen replacement: pharmacokinetics and peripheral conversion to androgens and estrogens in young healthy females after dexamethasone suppression.
    Arlt W; Justl HG; Callies F; Reincke M; Hübler D; Oettel M; Ernst M; Schulte HM; Allolio B
    J Clin Endocrinol Metab; 1998 Jun; 83(6):1928-34. PubMed ID: 9626121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Levels of plasma steroid glucuronides in intact and castrated men with prostatic cancer.
    Bélanger A; Brochu M; Cliche J
    J Clin Endocrinol Metab; 1986 May; 62(5):812-5. PubMed ID: 2937801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum steroids remain within the same normal postmenopausal values during 12-month intravaginal 0.50% DHEA.
    Ke Y; Gonthier R; Simard JN; Archer D; Lavoie L; Martel C; Vaillancourt M; Labrie F
    Horm Mol Biol Clin Investig; 2015 Dec; 24(3):117-29. PubMed ID: 26509785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A sensitive, simple and robust LC-MS/MS method for the simultaneous quantification of seven androgen- and estrogen-related steroids in postmenopausal serum.
    Ke Y; Bertin J; Gonthier R; Simard JN; Labrie F
    J Steroid Biochem Mol Biol; 2014 Oct; 144 Pt B():523-34. PubMed ID: 25158021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Six-month oral dehydroepiandrosterone supplementation in early and late postmenopause.
    Stomati M; Monteleone P; Casarosa E; Quirici B; Puccetti S; Bernardi F; Genazzani AD; Rovati L; Luisi M; Genazzani AR
    Gynecol Endocrinol; 2000 Oct; 14(5):342-63. PubMed ID: 11109974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of oral dehydroepiandrosterone (DHEA) in the ovariectomised cynomolgus monkey.
    Leblanc M; Labrie C; Bélanger A; Candas B; Labrie F
    J Steroid Biochem Mol Biol; 2002 Jun; 81(2):159-64. PubMed ID: 12137806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Panhypopituitarism as a model to study the metabolism of dehydroepiandrosterone (DHEA) in humans.
    Young J; Couzinet B; Nahoul K; Brailly S; Chanson P; Baulieu EE; Schaison G
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2578-85. PubMed ID: 9253337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Wide distribution of the serum dehydroepiandrosterone and sex steroid levels in postmenopausal women: role of the ovary?
    Labrie F; Martel C; Balser J
    Menopause; 2011 Jan; 18(1):30-43. PubMed ID: 20683211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of finasteride on serum levels of androstenedione, testosterone and their 5α-reduced metabolites in men at risk for prostate cancer.
    Stanczyk FZ; Azen CG; Pike MC
    J Steroid Biochem Mol Biol; 2013 Nov; 138():10-6. PubMed ID: 23474436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A low dose (6.5 mg) of intravaginal DHEA permits a strictly local action while maintaining all serum estrogens or androgens as well as their metabolites within normal values.
    Labrie F; Martel C
    Horm Mol Biol Clin Investig; 2017 Feb; 29(2):39-60. PubMed ID: 27997350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 60.